positions available now

Blog

Commercial Eyes Proudly Celebrates 20th Birthday!

From humble beginnings and with big aspirations, on this day 20 years ago Commercial Eyes was founded and over the last two decades has grown to be the foremost therapeutics commercialisation business in Australia and New Zealand.

The Commercial Eyes name was chosen because it epitomised the company’s reason for being.  Quite simply, to commercialise therapeutic goods so that patients and healthcare professionals have access to the medicines and medical technology they need.

Hundreds of thousands of project hours later, Commercial Eyes has become an industry household name, recognised for delivering successful outcomes, consistent lofty standards, excellent staff, and influence.

Today, many hundreds of therapeutics are available, in part due to the splendid work of the Commercial Eyes team. Whether it be the design of a market entry or lifecycle management strategy, the mapping of a patient journey, the design and preparation of a literature based regulatory submission, the writing of a risk management plan, the production of a reimbursement or funding application, the crafting of impactful medical communications, the building of a digital platform for a unique patient access or support program, the answering of thousands of medical enquiries or processing of hundreds of adverse events; true to our ambition, in partnership with over 650 pharmaceutical and medical device companies, Commercial Eyes has made a significant and lasting contribution to the biopharmaceutical and medtech sector of this region.

We have also built a 20-year legacy of championing workplace equality, diversity, flexibility, and community engagement.  Commercial Eyes is a place where it has always been ‘normal’ to see women in leadership, where pay equity is a starting position, where colleagues enjoy morning teas and team lunches and their culinary contributions represent a global smorgasbord and a place where staff have always been encouraged to embrace part-time and flexible work arrangements.

Commercial Eyes has always valued diverse industry experience and technical expertise and for many, facilitated a first step into the biopharmaceutical and MedTech sector. Over 20 years, we are very proud to have contributed to our teams’ professional development and provided really interesting and varied job opportunities to over 300 great people.

Through the Commercial Eyes community engagement program, we have generously supported over 30 community partners, with an emphasis on indigenous education and healthcare services. We have cared for the disadvantaged, supported healthcare workers and social programs and assisted thousands of vulnerable people in Australia and beyond.

A big thank you to our staff (past and present), clients, partners, and supporters for contributing to Commercial Eyes’ amazing story and helping us to reach this special milestone!

We look forward to all of you playing a part in shaping our next exciting chapter.

Happy 20th Birthday!

Posted in Commercial Eyes, Life Sciences Industry | Tagged , , | Comments Off on Commercial Eyes Proudly Celebrates 20th Birthday!

How will the new Strategic Agreements impact your business?

Medicines Australia and Generic and Biosimilars Association have secured new 5 year agreements with the Commonwealth for timely access to and reimbursement of medicines and policy settings that recognise the value of innovative and generic medicines to patients and the community.  These changes will impact all industry stakeholders.

Both agreements are now aligned to commence on 1 July 2022 and run for 5 years.

Medicines Australia Agreement

The MA agreement focuses on prioritising the value of F1 medicines and timely access, while securing $2.8 billion in new investment, a review of Health Technology Assessment (HTA) and other policy reforms including a new framework for Risk Share Agreements (RSA).

Key provisions secured for the innovator industry include:

  • Comparators: A confirmation that the PBAC is the appropriate decision-making body as to the appropriate comparator (regardless of whether it is the lowest cost comparator) (subject to further work in HTA Review)
  • Discount rate: priority review to take place immediately to align with international best practice and to commence in July 2022
  • Savings reinvested: savings made through reforms will be reinvested into new medicines on the PBS
  • Removal of the cost offsets policy:  agreed in 2020 but secured now in this Strategic Agreement as part of the New Medicines Funding Guarantee of at least $2.8bn.
  • Confirmation/ no change to criteria for special pricing arrangements
  • Policy reforms aimed at faster access:  conditional listing to be considered, enhanced consumer access, more balanced policy framework for RSAs that will enable sponsors to make decisions and negotiate arrangements for their products/patients.

A HTA Review (to be implemented by July 2024) will focus on key issue areas including:

  • Selection of comparators
  • Methods for evaluating medicines for rare diseases/cell and gene therapies/precision medicines for reimbursement/alternative funding pathways/suitability of existing pathways
  • Methods for evaluating all new medicines and vaccines
  • Use of real world evidence and other sources of evidence other than randomised controlled trials
  • Managing clinical, economic, financial and other uncertainty
  • Examining feasibility of international work sharing for reimbursement submissions

Generic and Biosimilar Medicines Association Agreement

The GBMA Strategic Agreement focuses on a package of policy settings and incentives, including floor prices and stockholding requirements, for companies to maintain sufficient stock of their broad portfolios of medicines in Australia. GBMA are also looking at policy initiatives to enhance repurposing of medicines to expand patient access and further uptake drivers for the increased use of biosimilars.

Key new provisions relevant to generic and biosimilar medicines sponsors are:

  • Single branded drug discounts removed: The Commonwealth will seek to negotiate outcomes at an individual sponsor level to remove the ability of single branded drugs (that should be interchangeable with multi-branded drugs) to sell at discounted prices below their Approved Ex- Manufacturer Price (AEMP) or with incentives, in competition with multi-branded drugs. 
  • Early removal of originator brand from price disclosure calculations: where no price reduction for first three price disclosure cycles, originator brand will be removed from Weighted Average Disclosure Price from the 4th cycle (ie, after 18 months instead of current 30 months). Inclusion of public hospital pricing will also be introduced to Price Disclosure calculations for the first time.
  • 30% price disclosure continues, but modified: threshold reached after later of 7 price disclosure cycles after drug is on F2 or 5 cycles after first price disclosure reduction
  • Floor price (minimum ex-manufacturer price) applied for low cost listed brands and not subject to further price disclosure reductions

*some conditions apply where AEMP >$4, further details to be provided.

  • Stockholding requirement to be implemented by 1 July 2023: companies will need to hold default supply (4-6 months) of Listed Brands that have a Floor Price.
  • Significant penalties relating to listed brands with floor prices: risk of revocation of PBS listing if pass on discounts or incentives for these products and for low stock levels/ failure to supply
  • Temporary PBS listing options for s 19A medicines

Statutory Price Reductions  

All sponsors should be aware of key changes to pricing mechanisms:

  • Savings measures: $1.9 billion in savings will be delivered over the course of the agreement through mechanisms including adjustments to the Statutory Price Reduction mechanisms
  • Changes to price reductions:
Statutory Price Reduction
  • Catch up reductions for anniversaries falling in 2021/2022 to take effect on 1 April 2023.
  • Price reduction mechanisms will also apply for combination drugs where one of the listed drugs is subject to price reduction.

How can Commercial Eyes help?

Market Access and Pricing: Given these important changes to pricing for PBS medicines in the new Medicines Australia and GBMA agreements, Commercial Eyes offers a portfolio pricing review service should you require an understanding of the implications of the pricing components on your portfolio. This leverages our MAP Insights database, which holds an extensive history of all PBS item pricing.

Market Insights: New strategic agreements provide important insights into the direction of the industry and the changing landscape for medicines policy and access.  Commercial Eyes offers all our clients landscape assessments, market feasibilities and strategic insights to assess your future needs in this context. 

Stakeholder engagement: Commercial Eyes can provide advice and support for your stakeholder engagement objectives.  We can also support you to understand and inform your global teams of the terms of these agreements and the implications for the next 5 years and beyond in the context of the broader landscape.

As a member of both Medicines Australia and GBMA, Commercial Eyes will continue to follow and take an active role in the implementation of these Agreements.

For more information, please contact us at [email protected]

Posted in Life Sciences Industry, Market Access, Market Insight | Tagged , , , , | Comments Off on How will the new Strategic Agreements impact your business?

Administrator, Regulatory, Quality & Compliance

About us 

Commercial Eyes is the foremost life sciences commercialisation business in Australia and New Zealand. With a team of over 100 people and 20 years of expertise, we have assisted more than 650 pharmaceutical, medical device, diagnostic and consumer healthcare companies.  

No other life sciences commercialisation consultancy offers the full suite of services we do; market insight and analysis including competitive intelligence, registration, pricing and reimbursement/health economics, patient support, medical information, pharmacovigilance and medical communications.  

About the role 

This is a great opportunity to join a diverse and experienced team inspired to deliver work that makes a difference to people’s lives. You will be responsible for providing day-to-day administrative assistance to the Head of Regulatory, Quality & Compliance, as well as undertaking project related administrative functions, including: 

  • Co-ordinating and ensuring delivery of regulatory submissions to TGA and Medsafe by the specified date, including liaising with all third-party suppliers. 
  • Assisting the Regulatory, Quality & Compliance team with tracking of regulatory projects and tracking and storage of regulator and client communications. 
  • Assisting with Quality Management System activities such as documentation preparation and liaising with Quality Group Delegate(s) for implementation and roll out of SOPs and other related documents. 
  • Managing the business unit’s training database. 

This role is initially a parental leave cover position reporting to the Head of Regulatory, Quality & Compliance. However, the breadth of consultative services offered by Commercial Eyes and our plans for expansion, will create potential opportunities for you to continue developing your career with us. 

About you

This is an exciting opportunity for someone that is process driven, loves being exposed to diverse projects, feels energised working and learning from different people and enjoys coordinating projects and teams.  

The key attributes / experience we would love you to bring to the team are:  

  • Science/biotech background and previous work experience in a medical or regulatory environment. 
  • Demonstrated strong administrative skills. 
  • Proficient computer skills and in-depth knowledge of Microsoft Office (Word, Outlook, PowerPoint, Excel, Access). 
  • Demonstrated experience managing confidential and sensitive information and sound judgement when interacting with clients and staff. 

Why Commercial Eyes? 

  • Our values of Respect, Flexibility, Generosity, Resourceful and Excellence define who we are and the decisions we make.  
  • At CEPL you are not just a number, you become a member of a team who supports and cares for each other. Everyone gets to know each other by name regardless of where you work from. 
  • We value diversity and pride ourselves on having a strong representation of women in our Senior Leadership Team, which is unique within our industry. 
  • Our team is multicultural and diverse, so you’ll get to work with a variety of people from different ethnicities, beliefs and with a broad range of experiences. 
  • We are committed to supporting the community in which we work. The projects we support are both sustainable and recurrent including: Yalari, The Smith Family, The Purple House, Australian Red Cross and more.  
  • Our Managing Director, Andrew Carter, is the president of ARCS Australia. We are known for our capabilities and outcomes across the sector and our network spans industries, including pharmaceuticals, medical devices, consumer health products and biotechnology. 
      

The Rewards

  • Health and Wellbeing: 

Our people get access to our EnergEyes Program, which include an annual wellbeing allowance that you can use to support your health and wellbeing including but not limited to gym memberships, fitness clothing/equipment, yoga and massage/physio sessions. 

Our people get access to our EnergEyes Program, which include an annual wellbeing allowance that you can use to support your health and wellbeing including but not limited to gym memberships, fitness clothing/equipment, yoga and massage/physio sessions. 

  • Birthday Reward: An additional day of paid leave just for your birthday. 
  • Tenure Reward: One day of paid leave for each completed year of completed service (maximum 5) 
  • Company conferences and team building activities: We love every opportunity we get to get together to learn, connect and have fun. When travel is allowed, we love hosting our Staff Annual Conference at the end of each financial year and our Christmas Function in December. However, when we can’t make it happen in person, we do our best to recreate the experience online.  

Continue the conversation  

If you think this role might be for you and joining the CEPL family gets you excited, please submit your application via seek as soon as possible. The shortlisting process will commence on Thursday 29th July. 

If you are shortlisted for this role, this is what you can expect throughout the process: 

  • Phone screening interview with a member of our People, Learning and Performance Team  
  • First interview with our Talent Acquisition & Inclusion Manager 
  • Second interview with the hiring Manager  
  • Psychometrics tests  
  • Reference checks  

 

Here at Commercial Eyes we value diversity and inclusion and consider all candidates equally. 

 

Please note: 

  • Commercial Eyes does not accept applications from recruitment agencies.  
  • To apply for this role you must be a permanent resident or citizen of Australia.   

 

Apply here

 

If you have any questions or would like more information, email our People, Learning & Performance department at [email protected] 

Posted in Commercial Eyes, Commercialisation Services, Life Sciences Industry, Recruiting, Regulatory Services | Tagged , , , | Comments Off on Administrator, Regulatory, Quality & Compliance

Commercial Eyes Recruiting: Quality ISO Specialist

 

The Opportunity 

Reporting to the Executive Director, the Quality ISO Specialist is responsible for managing and maintaining the ISO 9001 certified Commercial Eyes Quality Management System (QMS) and for its operational efficiency and excellence. The role leads activities to ensure the integrity of the quality system is maintained and all employees are committed to a quality culture, which includes: document and record control, individual/group training processes, external audit participation, conducting internal audits, vendor assurance, client feedback and handling, and CAPA & deviations.  

 

Duties 

  • Lead, drive & act as subject matter expert in QMS and provide support to the wider company. 
  • Ensure the development, implementation and maintenance of the QMS and that it meets the requirements of ISO 9001/2015 standard. 
  • Manage testing, validation, and implementation activities for QMS systems as required. 
  • Chair Quality Group meetings and ensure follow up and completion of actions. 
  • Draft, review and implement new documents or edit existing controlled documents within the Quality document control module. 
  • Manage the CAPA System – Initiate and review corrective preventive actions and deviations and support SME’s in delivering Corrective Action Plans. 
  • Manage and lead the company wide internal audit process. 
  • Manage client RFP, vendor assurance and due diligence requests. 
  • Ensure that Business audit ready, keeping all relevant QMS documents up to date. 

 

Position Requirements 

  • Business or Science degree. 
  • Proven record in systems development. 
  • Pharma experience desirable however not essential. 
  • Detailed knowledge of quality systems principles including quality and business excellence models (e.g. ISO 9001/2015). 
  • Experience conducting quality assessments and audits. 
  • Knowledge of and experience with QMS including documentation management. 
  • Project management, process development and organisational skills 
  • Demonstrated quality/continual improvement focus. 
  • Highly developed organisational and problem solving skills. 
  • Demonstrated aptitude for CRM and other computer software such as Microsoft Suite. 
  • Excellent written and oral communication skills including communication of scientific data. 
  • High level of attention to detail. 
  • Adaptability. 
  • Ability to prioritise work and use good judgment. 

 

The Rewards 

  • Be part of an inclusive and diverse working environment. 
  • Be a member of a team who supports and cares for each other. 
  • Work for a company consistently delivering excellence. 
  • Deliver work that makes a difference to people’s lives through health. 

 

Please note: 

  • Commercial Eyes does not accept applications from recruitment agencies.  
  • To apply for this role you must be a permanent resident or citizen of Australia.   

 

Here at Commercial Eyes we value diversity and inclusion and consider all candidates equally. 

If you would like more information or would like to apply, email our People, Learning & Performance department at [email protected]

Posted in Commercial Eyes, Life Sciences Industry, Recruiting | Tagged , , , , | Comments Off on Commercial Eyes Recruiting: Quality ISO Specialist

Commercial Eyes Recruiting: Consultant, Regulatory, Quality & Compliance

 

The Opportunity

The Consultant works within the Regulatory, Quality & Compliance team to deliver a range of regulatory applications for Australia and New Zealand.  The Consultant manages client projects, working closely with other members of the team, to deliver a superior client experience, optimise project outcomes, and contribute to the culture and capabilities of the team.

 

Duties

  • Manage the registration and listing of medicines or medical devices in Australia and New Zealand.
  • Provide support on regulatory activities requiring a sound knowledge of the type and quality of evidence necessary for new medicines registrations or medical device inclusions, as well as related life cycle management activities.
  • Provide strategic advice to clients regarding the Australian and New Zealand regulatory environment.
  • Review, critical evaluate, prepare and submit regulatory dossiers to the TGA and Medsafe.
  • Assist in the preparation of literature-based submissions, including the preparation of associated overviews and summaries.
  • Assist senior members of the team in the preparation of complex regulatory applications for submission to the TGA and other regulatory agencies.
  • Assist clients with the maintenance of current registrations and listings.
  • Assist clients in responding to regulatory agency questions.
  • Attend meetings/teleconferences with clients and/or TGA or Medsafe as required.
  • Undertake project and client management as required.
  • Mentor junior staff as required.
  • Build strong interpersonal networks across the life sciences sector and draw on these to identify potential short and long-term business opportunities for Commercial Eyes.
  • Assist with development of proposals.
  • Liaise with other groups within Commercial Eyes as required.

 

Position Requirements

  • Undergraduate qualifications in pharmaceutical sciences or other scientific discipline.
  • A minimum of 5 years’ experience in Australian and New Zealand regulatory affairs, preferably in a commercial environment.
  • Experience in the review, critical evaluation and presentation of clinical data.
  • Good knowledge of TGA and Medsafe legislation, regulations, guidelines and working procedures.
  • Reasonable computer literacy.
  • Proven experience dealing with a high level of confidentiality.
  • Proven problem solving and project management skills.
  • Attention to detail.
  • Interest in the practice of consulting.
  • High level written and oral communication skills.

 

Preferable requirements:

  • Post-graduate qualifications in a relevant discipline.
  • Previous consulting experience.
  • Willingness to travel as required.

 

The Rewards

  • Work for a company consistently delivering excellence.
  • Deliver work that makes a difference to people’s lives through health.
  • Be a member of a team who supports and cares for each other.
  • Be part of an inclusive and diverse working environment.

 

Please note:

  • Commercial Eyes does not accept applications from recruitment agencies.
  • To apply for this role you must be a permanent resident or citizen of Australia. 

 

Here at Commercial Eyes we value diversity and inclusion and consider all candidates equally.

If you would like more information, email our People, Learning & Performance department at [email protected]

Posted in Commercial Eyes, Recruiting, Regulatory Services | Tagged , , , , | Comments Off on Commercial Eyes Recruiting: Consultant, Regulatory, Quality & Compliance

Commercial Eyes recruiting: Associate Consultant, Regulatory, Quality & Compliance

 

 

The Opportunity

The Associate Consultant works within the Regulatory, Quality & Compliance team to contribute to the regulatory, quality and compliance consulting practice. The Associate Consultant is responsible for the preparation and submission of a range of regulatory applications, compliance documents and related activities for Australia and New Zealand. The Associate Consultant supports the delivery of a variety of projects, working closely with the Regulatory, Quality & Compliance Administrators, Associates, Associate Consultants, Consultants, Senior Consultants, Project Leaders, Manager and/or Associate Director to deliver a superior client experience and optimise project outcomes.

 

Duties

  • Provide support to clients on the registration and listing of medicines or medical devices in Australia and New Zealand.
  • Provide support to clients with the maintenance of current registrations and listings.
  • Review, critically evaluate, prepare and submit regulatory dossiers to the TGA and Medsafe.
  • Assist clients in responding to TGA and Medsafe questions.
  • Develop a subject matter expert area(s).
  • Review and QC applications, regulatory, quality and compliance documentation as required.
  • Mentor and/or train junior staff as required.
  • Liaise with other groups within Commercial Eyes as required.
  • Other reasonable duties as requested.

 

Position Requirements

  • A minimum of 3 years of experience in Australian and New Zealand regulatory affairs, preferably in a commercial environment.
  • Good knowledge of TGA and Medsafe legislation, regulations, guidelines and working procedures.
  • Reasonable computer literacy.
  • Good problem solving and project management skills.
  • Ability to work to deadlines.
  • Attention to detail.
  • Excellent written and spoken communication and interpersonal skills.
  • Reliable.
  • Interest in the practice of consulting.
  • An appetite for learning and development.

 

The Rewards

  • Work for a company consistently delivering excellence.
  • Deliver work that makes a difference to people’s lives through health.
  • Be a member of a team who supports and cares for each other.
  • Be part of an inclusive and diverse working environment.

 

Please note:

  • Commercial Eyes does not accept applications from recruitment agencies.
  • To apply for this role you must be a permanent resident or citizen of Australia. 

 

Here at Commercial Eyes we value diversity and inclusion and consider all candidates equally.

If you would like more information, email our People, Learning & Performance department at [email protected]

Posted in Commercial Eyes, Commercialisation Services, Recruiting, Regulatory Services | Tagged , , | Comments Off on Commercial Eyes recruiting: Associate Consultant, Regulatory, Quality & Compliance

New TGA framework to redefine personalised medical devices

A new Therapeutic Goods Administration (TGA) framework will commence on 25th February 2021, changing the definitions of personalised medical devices and the way they are regulated.  

Personalised medical devices are medical devices produced to suit the needs of a particular individual. Previously, personalised medical devices included “Custom-made medical devices” and “Adaptable medical devices”, of which the former was exempt from inclusion in the Australian Register of Therapeutic Goods (ARTG).  

The new regulatory framework continues to exempt custom-made devices from inclusion on the ARTG; the primary change being that the scope of products that meet the definition has been reduced by introducing new concepts; “Patient matched medical devices” and “Devices produced using the Medical Device Production System (MDPS)”. Both new types of devices will require inclusion on the ARTG from 25 February 2021.  As a general guide, manufacturing, importing, or supplying more than five (5) of a kind of medical device in a year would make it unlikely for these devices to remain classified as “custom-made medical devices” under the new framework.   

TGA Medical Devices Framework

Patient matched medical devices are medical devices matched to a patient’s anatomy within a specified design envelope using techniques such as scaling of the device and are typically produced in batches through a controlled process. Manufacturers and suppliers with patient-matched medical devices will need to liaise with the TGA on transition arrangements by 25 August 2021 and inclusion applications will need to be submitted prior to 1 November 2024.   

MDPS refers to a validated, multi-component design and production system that can be supplied to healthcare professionals and facilities for the production of specific patient-matched medical devices. Devices produced using MDPS will need to be included on the ARTG and supplied with instructions to enable the safe production of devices that meet their intended purpose.   

In addition to the new definitions in the framework, while custom-made medical devices will continue to be exempt from inclusion on the ARTG, there are new obligations on the information to be supplied with the device, such as record keeping and reporting, and regulator inspection and review, which are required to be met from 25 February 2021.    

 

If you are a manufacturer, supplier or sponsor affected by this change and you need assistance on the next steps, please contact our Regulatory, Quality & Compliance team at [email protected]

Posted in Compliance, Life Sciences Industry, Medical Device, Regulatory Services, TGA | Tagged , , , | Comments Off on New TGA framework to redefine personalised medical devices

Commercial Eyes acquires Open Sesame Consulting

We are very excited to announce today the acquisition of Open Sesame Consulting by Commercial Eyes. 

Commercial Eyes is Australia’s leading pharmaceutical and medical device commercialisation consultancy.  Commercial Eyes employs over 100 staff and this year celebrates 20 years of operation. Commercial Eyes provides a broad range of commercialisation services in the regulated therapeutics industry, including Regulatory Services, Market Access, Market Insights, Medical Communications, Patient Engagement, Medical Information and Pharmacovigilance.  

Open Sesame Consulting is a leading healthcare consulting company specialising in health economics, funding and reimbursement for medical devices and therapeutic services. Sue John of Open Sesame Consulting has extensive international and local experience over 25 years working for a wide range of medical device companies to secure product reimbursement and support sales with health economics data.   

“We are excited to announce this acquisition and continue to add value to those businesses that Sue John has worked with. As the demand for services in the medical device and diagnostic sector continues to grow for our business, we welcome the opportunity to work closely with Sue to expand our offering and include greater depth in the reimbursement of medical devices. With the increasing convergence of medical technology and overlap in funding sources for some new therapies, this expansion is very logical.   

We have always taken a broad view in supporting clients with all aspects of commercialisation of pharmaceutical and medical devices. Having worked with Sue over many years we understand the requirements of this space and know this will greatly complement our existing offering.”

Andrew Carter said

“I cannot think of a better partner than Commercial Eyes to continue the work I have supported my clients with. I look forward to working closely with the Commercial Eyes team to share my experience and ensure a seamless transition for the clients I have worked with over many years.” 

Sue John said

 

Commercial Eyes is headquartered in Melbourne, with staff in most capital cities around Australia.  

 

For further information please contact Simon Higgins (General Manager Commercialisation Services) on 0478 486 894 or at [email protected]

 

Posted in Commercial Eyes, Commercialisation Services, Life Sciences Industry, Medical Device, Medical Services | Tagged , , , | Comments Off on Commercial Eyes acquires Open Sesame Consulting

Season’s greetings from Commercial Eyes

To all our clients, associates and followers. We wish you all the best over the holiday period as well as a safe and happy new year.

Read more about the organisations Commercial Eyes has proudly supported over 2020, and how we have helped make a difference to communities across Australia.

Commercial Eyes is proud to have partnered with Yalari since 2009.

Yalari is a not-for-profit organisation that offers quality, secondary education scholarships at leading Australian boarding schools for Indigenous children from regional, rural and remote communities.

They believe education is the key to generational change and a brighter future for Indigenous Australians and for our nation, as well as deeply committed to the ongoing success of our national program of scholarships, student support and post-school opportunities.

We have sponsored a wonderful student from the Northern Territory, who this year is completing year 10 at Geelong Grammar School.

She returned to her hometown in Darwin as a result of the pandemic, to learn remotely with the support of her teachers.

After restrictions were eased, she arrived back in Melbourne to finished the year, surrounded by friends and an encouraging outlook for 2021.


Commercial Eyes has been a proud supporter of The Smith Family Book & Toy Appeal for the past several years. In 2019 Commercial Eyes contributed by donating over 50 books and toys that helped bring a smile to disadvantaged children.

Sadly, thousands of Australian kids will go without receiving a gift this holiday season simply because their families can’t afford it. The gifts provide children in need to feel a sense of belonging at Christmas, and help the acquire the skill and knowledge they need to build a better future.

Due to COVID-19 we had to donate in a different way, and raised nearly $1,000 thanks to our generous staff.

We are thankful to everyone who donated, and are pleased to be supporting this incredible initiative through online fundraising!


Donations to the Leukaemia Foundation transform fear into hope in miraculous ways by furthering the work of brilliant research scientists who are uncovering life-saving advancements in blood cancer diagnosis and treatment.

Commercial Eyes is honoured to partner with the only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and live a better quality of life.

This year we did something a different, we raised much needed funds and awareness through a virtual company trivia night.

The night was a huge success, and as well as night full of laughs and overly competitive teams, we raised a total of $5,000 from generous staff, family and friends.

Posted in Commercial Eyes | Tagged | Comments Off on Season’s greetings from Commercial Eyes

A thriving business in dormant times

 

Do you remember saying – “I catch the train to get to work”?  What about “I’m leaving work in the next half an hour and I’ll pick something up at the supermarket on the way home”. I miss saying those things.

The Commercial Eyes office is in Melbourne’s CBD and is contemporary, full of light and space. Most baristas would cherish working behind our coffee machine and the bowls of fruit and jar of biscuits just seem to fill themselves.

We are in the business of assisting clients bring their medicines, medical devices, and diagnostics to the Australian market. It is a complex task, often difficult to navigate, and requires the contribution of many players. We are just one, and the end goal is to ensure that Australian patients get access to the medicines and healthcare products they need.

Today, our Melbourne office is dormant. It feels lifeless and a bit sad, even the plants look jaded. Only a handful of our nearly 100 employees have been to the office in the past six months. I miss it! Simply because it means that I can’t physically be with the Commercial Eyes team. I think the quid pro quo of needing to be so reliant on our contemporary communication tools, is acknowledging the diminishing effect they have on spontaneity, passion, and generally having fun at work.

That said, our business is thriving! Our technology, systems and databases are doing exactly what they are designed to do. Our staff have mastered them, are working productively, and are connected, to each other and our clients – in some cases more than ever. We are seeing communication advancements and innovation on a regular basis.

Ensuring access to essential medicines and innovative health technology is fundamental to a fair and vibrant society. COVID19 restrictions have had a big impact on where our people do their work; in some ways COVID19 has impacted how we work; most importantly, it underscores the importance of what we do.

Posted in Commercial Eyes|Life Sciences Industry | Tagged | Comments Off on A thriving business in dormant times
Copyright © 2020 Commercial Eyes